BenevolentAI logo

BenevolentAI

Verified

BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.

Visit Official Website

BenevolentAI at a glance

What it is
BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.
Who it's for
Most useful for anyone who needs results in the AI Healthcare, Wellness & Medical area without a specialist on staff.
Primary use case
Common uses range from one-off experiments to repeatable production work in the AI Healthcare, Wellness & Medical space.
  • CategoryAI Healthcare, Wellness & Medical
  • PricingFree Tier
  • Starting priceFree, paid plans available
  • Credit cardNo credit card required
  • Foundation modelFine-tuned
  • Bring your own keyNot supported
  • RatingNo reviews yet. Be the first to rate.

Video Spot

No creator video yet. “Stop Getting Lost in the AI Labyrinth” — the official Zoipi platform showcase.

Overview

BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery.

In detail

BenevolentAI is a company that applies advanced artificial intelligence to biopharma drug discovery. It is aimed at pharmaceutical and biotech organizations seeking to accelerate the process of identifying and developing new drugs, rather than at individual consumers. The company is publicly listed on Euronext Amsterdam under the ticker BAI.

Beyond this, the website content could not be read, so details on how the platform works internally, its specific AI methods, feature set, and what distinguishes it from other drug discovery AI companies are not available. Interested parties should consult BenevolentAI's own site or investor materials for further specifics on its technology and offerings.

Common uses

  • Accelerating biopharma drug discovery for pharmaceutical companies

Pros

  • Focused specifically on applying AI to drug discovery
  • Publicly listed company (Euronext Amsterdam: BAI)

Cons

  • Website content could not be read, so specific features and capabilities are unknown
  • No details available on pricing, plans, or trial options

Generated from the listing's details and not yet checked by a Zoipi editor.

Key Features

  • BenevolentAI (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery
  • Dedicated ai healthcare, wellness & medical workspace
  • Browser-based, nothing to install

Best For

  • Anyone replacing a manual ai healthcare, wellness & medical process with something faster
  • Anyone testing the space without an upfront budget
  • Buyers who want a highly rated, well-established option

Pricing Model

Free Tier. Generous ongoing free tier you can start with, no credit card needed. Paid plans unlock higher limits.

Pricing Breakdown

Starting price
Free, paid plans available
Free trial / credits
Ongoing free tier, no time limit
Credit card
No credit card required
Freemium

Screenshots

Live preview of BenevolentAI's website.

Frequently asked questions

It is used to apply advanced AI to accelerate biopharma drug discovery.

Community Reviews & Discussion

0 reviews · replies are moderated before they appear.

  • No reviews yet — be the first to review BenevolentAI.